{
    "@context": "https://schema.org",
    "@type": "Article",
    "headline": "Personalized Medicine: 2021 FDA Guideposts for Progress",
    "url": "https://www.lexblog.com/2022/03/03/personalized-medicine-2021-fda-guideposts-for-progress/",
    "identifier": {
        "@type": "PropertyValue",
        "name": "LexBlog Library record",
        "value": "LEX-WK-Z9B7MBCX",
        "url": "https://www.lexblog.com/lib/Z9B7MBCX/"
    },
    "datePublished": "2022-03-03T15:16:14-05:00",
    "dateModified": "2022-03-03T17:09:28-05:00",
    "author": {
        "@type": "Person",
        "name": "Antoinette F. Konski"
    },
    "sourceOrganization": {
        "@type": "Organization",
        "name": "Foley & Lardner LLP"
    },
    "organizationScope": "at-publication",
    "isPartOf": "Personalized Medicine Bulletin",
    "about": "Health Care and Life Sciences",
    "sourceUrl": "https://www.foley.com/en/insights/publications/2022/03/personalized-medicine-2021-fda-guideposts-progress",
    "sourceStability": "may-move"
}